Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
1999
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Low Density Lipoprotein Receptor-related Protein-mediated Membrane Translocation of 12/15-Lipoxygenase Is Required for Oxidation of Low Density Lipoprotein by Macrophages
2003
Long COVID: major findings, mechanisms and recommendations
2023 Standout
QM/MM Methods for Biomolecular Systems
2009 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Medical Treatment of Peripheral Arterial Disease and Claudication
2001
Contribution of platelets to tumour metastasis
2011 Standout
A comprehensive map of molecular drug targets
2016 Standout
Comparative effects of cilostazol and other therapies for intermittent claudication
2001
Cyclic Nucleotide Phosphodiesterase Activity, Expression, and Targeting in Cells of the Cardiovascular System
2003
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
2013 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Potentiation of C-type natriuretic peptide with ultrasound and microbubbles to prevent neointimal formation after vascular injury in rats
2003
Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome
2021
Pre-analytical and methodological challenges in red blood cell microparticle proteomics
2010
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Significance of microparticles in progressive systemic sclerosis with interstitial pneumonia
2008
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease
2006
Platelet Activation and Atherothrombosis
2007 Standout
Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential
2000
Diabetic neuropathy and nerve regeneration
2003
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
2008 StandoutNobel
Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction
2000
β2-Integrins and Acquired Glycoprotein IIb/IIIa (GPIIb/IIIa) Receptors Cooperate in NF-κB Activation of Human Neutrophils
2007
Diabetes and Atherosclerosis
2002 Standout
The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure
2022
Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions
2009
The potential role of platelet microparticles in atherosclerosis
2005
Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties
2008 Standout
Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs)
2005
How were new medicines discovered?
2011 Standout
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
2003 StandoutNature
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Analysis of the cilostazol safety database
2001
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
The purinergic component of human vas deferens contraction
2006
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel
2008
Progressive Lacunar Stroke: Review of Mechanisms, Prognostic Features, and Putative Treatments
2012
The creation of an antithrombotic surface by apyrase immobilization
2010 StandoutNobel
Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38
2008
Disruption of Nuclear Vitamin D Receptor Gene Causes Enhanced Thrombogenicity in Mice
2004
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
2018 Standout
Cilostazol: Potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding
2005
Characterization of a Catalytic Ligand Bridging Metal Ions in Phosphodiesterases 4 and 5 by Molecular Dynamics Simulations and Hybrid Quantum Mechanical/Molecular Mechanical Calculations
2006
Diversity‐Oriented Enantioselective Synthesis of Highly Functionalized Cyclic and Bicyclic Alcohols
2012 StandoutNobel
Effect of long-term treatment with $beta;-blocker on cardiac hypertrophy in SHR
1989
Contact between a polymer and whole blood: Sequence of events leading to thrombin generation
2001
Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease
1998
Diagnosing the decline in pharmaceutical R&D efficiency
2012 Standout
Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-κB binding to its recognition sequence
2001
5 Amidines and Guanidines in Medicinal Chemistry
1993
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Molecular and Biotechnological Aspects of Microbial Proteases
1998 Standout
Current and Future Drug Therapies for Claudication
1997
Mechanistic Studies on the Cu-Catalyzed Three-Component Reactions of Sulfonyl Azides, 1-Alkynes and Amines, Alcohols, or Water: Dichotomy via a Common Pathway
2008 StandoutNobel
Apoptosis During Regression of Cardiac Hypertrophy in Spontaneously Hypertensive Rats
1999
Additions to Metal-Activated Organonitriles
2002 Standout
Generation of a Small Library of Highly Electron‐Rich 2‐(Hetero)Aryl‐Substituted Phenethylamines by the Suzuki−Miyaura Reaction: A Short Synthesis of an Apogalanthamine Analogue
2004
Human Platelets Secrete the Plasma Type of Platelet-Activating Factor Acetylhydrolase Primarily Associated With Microparticles
2006
Use of Lawesson's Reagent in Organic Syntheses
2007 Standout
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
Cilostazol Has Beneficial Effects in Treatment of Intermittent Claudication
1998
Chemistry of Substituted Quinolinones. Part 8. Synthesis and Cyclization Reactions of Ethyl 5-Amino-1-(1-methyl-2-oxoquinolin-4-YL)-3-methylsulfanylpyrazole-4-carboxylate
2003
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption
2020
Phosphodiesterase 4D is required for β 2 adrenoceptor subtype-specific signaling in cardiac myocytes
2005 StandoutNobel
Microwave-Assisted Synthesis in Water as Solvent
2007 Standout
Formation of medium-ring heterocycles by diene and enyne metathesis
2007
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
Spatiotemporal dynamics of guanosine 3′,5′-cyclic monophosphate revealed by a genetically encoded, fluorescent indicator
2001 StandoutNobel
Cyclic Nucleotide Phosphodiesterase 1C Promotes Human Arterial Smooth Muscle Cell Proliferation
2002
Enhanced Levels of Oxidized Low-Density Lipoprotein Prime Monocytes to Cytokine Overproduction via Upregulation of CD14 and Toll-Like Receptor 4 in Unstable Angina
2007
Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack
2020
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Directed ortho Metalation - cross coupling connections. Total synthesis of Amaryllidaceae alkaloids buflavine and 8-O-demethylbuflavine
1998
Effects of cilostazol on resting ankle pressures and exercise-induced ischemia in patients with intermittent claudication
2001
Diabetic Somatic Neuropathies
2004 Standout
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
Section Review: Cardiovascular & Renal: Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseases
1995
Aryl−Aryl Bond Formation One Century after the Discovery of the Ullmann Reaction
2002 Standout
Effect of the Novel Antiplatelet Agent Cilostazol on Plasma Lipoproteins in Patients With Intermittent Claudication
1998
Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2
2001
Works of Yukio Kimura being referenced
Characterization of platelet aggregation in whole blood of laboratory animals by a screen filtration pressure method
2003
Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells
1990
Human T-cell leukemia virus type 1 protease protein expressed inEscherichia coli possesses aspartic proteinase activity
1993
Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhdbitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo
1997
2(1H)-Quinolinone derivatives as novel anti-arteriostenotic agents showing anti-thrombotic and anti-hyperplastic activities
1998
Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double‐injury model
2000
Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets
2003
Effects of a single local administration of cilostazol on neointimal formation in balloon-injured rat carotid artery
1999
An anti‐platelet agent, OPC‐29030, inhibits translocation of 12‐lipoxygenase and 12‐hydroxyeicosatetraenoic acid production in human platelets
1999
Effect of Cilostazol, a Phosphodiesterase III Inhibitor, on Experimental Thrombosis in the Porcine Carotid Artery
1999
Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats
1998
Comparative Study of Antiplatelet Drugs in Vitro
1999
Characterization of Whole Blood Aggregation with a New Type of Aggregometer by a Screen Filtration Pressure Method
2001
Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. III. N-Cyclohexyl-N-(2-hydroxyethyl)-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide and related compounds.
1983
Altered Structural Brain Networks Related to Adrenergic/Muscarinic Receptor Autoantibodies in Chronic Fatigue Syndrome
2020
Alpha-adrenolytic properties of apogalanthamine and azapetine analogs.
1985
Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells.
1992
Development and Assessment of Enzyme Immunoassay for Platelet-derived Microparticles
2001
On the Transportation of Spermatozoa in the Vas Deferens
2009
Cilostazol
1993
Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. I. Alkyl 4-(2-oxo-1,2,3,4-tetrahydro-6-quinolyloxy)butyrates and related compounds.
1983
Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor sepharose chromatography
1984
Effect of cilostazol on platelet aggregation and experimental thrombosis.
1985
Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome
2003
Dose-related inhibitory effects of the β-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats
1984
Cyclic AMP specific phosphodiesterase activity and colon cancer cell motility
2000
Effects of cilostazol. an antiplatelet drug, on smooth muscle cell proliferation after endothelial denudation in rats
1992